Epstein Secrets

esearch: Janney downgrades NWY, CLSA initiates ARW/AVT/TECD (op) & IM (uw) Key Research: UBS initiates PANW (neut) & upgrades MCRO LN and ELN (buy), Piper initiates KYAK (neut) Key Research: DB downgrades SGMS & initiates KYAK (buy), Bofa downgrades VALE, GS cuts DOM LN Key Research: Nomura upgrades

DA & revs inline, raising FY guidance, mainly in Maersk line EFTA00406719 (trading +1.0%) Astrazeneca ups guidance after selling Nexium rights to Pfizer, ups guidance (trading +0.70%) Salzgitter Q2 inline (post profit warning June 26th), leaves outlook unchanged (trading +1.5%) Merck Q2 good beat

out of the European Union, Prime Minister Boris Johnson is headed to EU headquarters to try to finish the job." Reuters (12/7, Baczynska, Chalmers, Piper) reports UK and EU leaders "will meet face-to- face to try to seal a post-Brexit trade deal after failing again to narrow their differences on Monda

ber and hold back the other EFTA00135850 half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses wil

vv.reuters.com/article/us-britain-eu/u1c-eu-leaders-to-meet-face-to-face-to-try-to- seal-brexit-trade-deal-idUSKBN28HOLW> (12/7, Baczynska, Chalmers, Piper) reports UK and EU leaders "will meet face-to-face to try to seal a post-Brexit trade deal after failing again to narrow their differences on Monday

those in December and hold back the other half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses wil

NT/SUPN (hold) ••• KBW upgrades LION, Raja initiates ERIC (mp), Roth initiates GSVC (buy) ••• Stifel initiates EVDY (buy), Citi upgrades AZN (buy), Piper assumes RKUS (ow) EFTA00370850 • Stifel cuts CWH (sell), Raja upgrades MAIN/RUTH and GRGI (strong buy) and cuts DFRG • Roth initiates GSVC (buy),

t Animal Health to Lilly for $5.4B (NOVN VX +2.3%, GSK LN +5.3%, LLY no volume) • Astrazeneca ADR's closed +8.8% yesterday on Sunday Times story of Pfizer talks (trading +6.9%) • Philips misses estimates, adjusted EBITA 12% light on HC + lighting, weaker EM & FX (trading -7.0%) • Accor O1 sales miss

out of the European Union, Prime Minister Boris Johnson is headed to EU headquarters to try to finish the job." Reuters (12/7, Baczynska, Chalmers, Piper) reports UK and EU leaders "will meet face-to-face to try to seal a post-Brexit trade deal after failing again to narrow their differences on Monda

those in December and hold back the other half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses wi

cap reinstates NDAQ (ow), Citi downgrades MOSNHS, DB initiates ADS (buy) ••• Jefferies upgrades ADBE (buy), JPM upgrades BSAC & downgrades RBCN ••• Piper upgrades ARMH, Roth adds DGIT to focus list, Stifel upgrades MLNX (buy) ••• SunTrust initiates APD/PX (buys) & upgrades ADS (buy) & cuts AXLL, GS cu

e year (and sixth worst day ever) closing -11.6% with talk of margin calls as newly listed PeptiDream fell 28% due to a cancellation of a pact with Pfizer. After the Australian close, Kevin Rudd announced he would accept the challenge of his successor Julia Gillard to stand for Labor leadership, with b